المؤلفون: Silveira DRA; Service of Hematology, Transfusion and Cell Therapy and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology, HCFMUSP, University of São Paulo Medical School, São Paulo, Brazil.; Department of Hematology, AC Camargo Cancer Center, São Paulo, Brazil., Quek L; Medical Research Council MHU, BRC Hematology Theme, Oxford Biomedical Research Center, Oxford Center for Hematology, WIMM, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.; Department of Hematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Santos IS; Internal Medicine Department, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil., Corby A; Medical Research Council MHU, BRC Hematology Theme, Oxford Biomedical Research Center, Oxford Center for Hematology, WIMM, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom., Coelho-Silva JL; Department of Medical Images, Hematology and Clinical Oncology, University of São Paulo at Ribeirao Preto Medical School, Ribeirao Preto, Brazil., Pereira-Martins DA; Department of Medical Images, Hematology and Clinical Oncology, University of São Paulo at Ribeirao Preto Medical School, Ribeirao Preto, Brazil., Vallance G; Department of Hematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Brown B; Medical Research Council MHU, BRC Hematology Theme, Oxford Biomedical Research Center, Oxford Center for Hematology, WIMM, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom., Nardinelli L; Service of Hematology, Transfusion and Cell Therapy and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology, HCFMUSP, University of São Paulo Medical School, São Paulo, Brazil., Silva WF; Leukemia Unit, Cancer Institute of São Paulo, University of São Paulo Medical School, São Paulo, Brazil; and., Velloso EDRP; Service of Hematology, Transfusion and Cell Therapy and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology, HCFMUSP, University of São Paulo Medical School, São Paulo, Brazil.; Leukemia Unit, Cancer Institute of São Paulo, University of São Paulo Medical School, São Paulo, Brazil; and., Lucena-Araujo AR; Department of Genetics, Federal University of Pernambuco, Recife, Brazil., Traina F; Department of Medical Images, Hematology and Clinical Oncology, University of São Paulo at Ribeirao Preto Medical School, Ribeirao Preto, Brazil., Peniket A; Department of Hematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Vyas P; Medical Research Council MHU, BRC Hematology Theme, Oxford Biomedical Research Center, Oxford Center for Hematology, WIMM, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.; Department of Hematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Rego EM; Service of Hematology, Transfusion and Cell Therapy and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology, HCFMUSP, University of São Paulo Medical School, São Paulo, Brazil.; Leukemia Unit, Cancer Institute of São Paulo, University of São Paulo Medical School, São Paulo, Brazil; and., Bendit I; Service of Hematology, Transfusion and Cell Therapy and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology, HCFMUSP, University of São Paulo Medical School, São Paulo, Brazil., Rocha V; Service of Hematology, Transfusion and Cell Therapy and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology, HCFMUSP, University of São Paulo Medical School, São Paulo, Brazil.; Department of Hematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.; Leukemia Unit, Cancer Institute of São Paulo, University of São Paulo Medical School, São Paulo, Brazil; and.

المصدر: Blood advances [Blood Adv] 2020 May 26; Vol. 4 (10), pp. 2339-2350.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/diagnosis , Leukemia, Myeloid, Acute*/genetics, Adult ; Brazil ; Humans ; Middle Aged ; Prognosis ; Proportional Hazards Models ; United Kingdom